BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 5498613)

  • 1. Evaluation of systemic antifungal agents in X-irradiated mice.
    Gordee RS; Matthews TR
    Appl Microbiol; 1970 Oct; 20(4):624-9. PubMed ID: 5498613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic antifungal activity of pyrrolnitrin.
    Gordee RS; Matthews TR
    Appl Microbiol; 1969 May; 17(5):690-4. PubMed ID: 5785951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amphotericin B and amphotericin B methyl ester ascorbate. I. Chemotherapeutic activity against Candida albicans, Cryptococcus neoformans, and Blastomyces dermatitidis in mice.
    Gadebusch HH; Pansy F; Klepner C; Schwind R
    J Infect Dis; 1976 Nov; 134(5):423-7. PubMed ID: 792355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro antifungal activity of BMS-181184 against systemic isolates of Candida, Cryptococcus, and Blastomyces species.
    Karlowsky JA; Zhanel GG; Balko TV; Zelenitsky SA; Kabani AM; Hoban DJ
    Diagn Microbiol Infect Dis; 1997 Aug; 28(4):179-82. PubMed ID: 9327245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A9145, a new adenine-containing antifungal antibiotic. II. Biological activity.
    Gordee RS; Butler TF
    J Antibiot (Tokyo); 1973 Aug; 26(8):466-70. PubMed ID: 4600794
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro and in vivo activities of SCH 56592 against Blastomyces dermatitidis.
    Sugar AM; Liu XP
    Antimicrob Agents Chemother; 1996 May; 40(5):1314-6. PubMed ID: 8723494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro antifungal activity of clotrimazole (Bay b 5097).
    Shadomy S
    Infect Immun; 1971 Aug; 4(2):143-8. PubMed ID: 4949484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of a new semisynthetic echinocandin, LY-303366, against systemic isolates of Candida species, Cryptococcus neoformans, Blastomyces dermatitidis, and Aspergillus species.
    Zhanel GG; Karlowsky JA; Harding GA; Balko TV; Zelenitsky SA; Friesen M; Kabani A; Turik M; Hoban DJ
    Antimicrob Agents Chemother; 1997 Apr; 41(4):863-5. PubMed ID: 9087508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of voriconazole and amphotericin B against Candida albicans, Candida krusei, and Cryptococcus neoformans in human cerebrospinal fluid.
    Al Jalali V; Sauermann R; Eberl S; Zeitlinger M
    Infection; 2019 Aug; 47(4):565-570. PubMed ID: 30725316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis, and Histoplasma capsulatum.
    Li RK; Ciblak MA; Nordoff N; Pasarell L; Warnock DW; McGinnis MR
    Antimicrob Agents Chemother; 2000 Jun; 44(6):1734-6. PubMed ID: 10817743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous infection with Blastomyces dermatitidis and Cryptococcus neoformans.
    Mounts A; Deepe GS
    Med Mycol; 1998 Feb; 36(1):47-50. PubMed ID: 9776812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Off-Patent Drugs That Show Synergism with Amphotericin B or That Present Antifungal Action against Cryptococcus neoformans and
    Rossi SA; de Oliveira HC; Agreda-Mellon D; Lucio J; Mendes-Giannini MJS; GarcĂ­a-Cambero JP; Zaragoza O
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31988099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological properties of aureobasidin A, a cyclic depsipeptide antifungal antibiotic.
    Takesako K; Kuroda H; Inoue T; Haruna F; Yoshikawa Y; Kato I; Uchida K; Hiratani T; Yamaguchi H
    J Antibiot (Tokyo); 1993 Sep; 46(9):1414-20. PubMed ID: 8226319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo activity of hamycin against Blastomyces dermatitidis.
    Shadomy S; Robertson GM; Shadomy HJ; Utz JP; Gamble E
    J Bacteriol; 1969 Feb; 97(2):481-7. PubMed ID: 5773006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Triazole NT-a9 Has Potent Antifungal Efficacy against Cryptococcus neoformans
    Lu RY; Ni TJ; Wu J; Yan L; Lv QZ; Li LP; Zhang DZ; Jiang YY
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31791946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanization of Cryptococcus neoformans and Histoplasma capsulatum reduces their susceptibilities to amphotericin B and caspofungin.
    van Duin D; Casadevall A; Nosanchuk JD
    Antimicrob Agents Chemother; 2002 Nov; 46(11):3394-400. PubMed ID: 12384341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quercetin and rutin as potential agents antifungal against Cryptococcus spp.
    Oliveira VM; Carraro E; Auler ME; Khalil NM
    Braz J Biol; 2016; 76(4):1029-1034. PubMed ID: 27166572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amphotericin B.
    Abadi J
    Pediatr Rev; 1995 Oct; 16(10):363-4. PubMed ID: 7479429
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative activities of UK-49,858 and amphotericin B against Blastomyces dermatitidis infections in mice.
    Lyman CA; Sugar AM; Diamond RD
    Antimicrob Agents Chemother; 1986 Jan; 29(1):161-2. PubMed ID: 3015001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New azasteroidal antifungal antibiotics from Geotrichum flavo-brunneum. III. Biological activity.
    Gordee RS; Butler TF
    J Antibiot (Tokyo); 1975 Feb; 28(2):112-7. PubMed ID: 1089623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.